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Summary 
The development of memory B cells takes place in germinal centers (GC) of lymphoid follicles 
where antigen-driven lymphocytes undergo somatic hypermutation and affinity selection,  pre- 
sumably under the influence of helper T cells. However, the mechanisms that drive this complex 
response are not well understood. We explored the relationship between GC formation and the 
onset of hypermutation in response to the hapten phosphorylcholine (PC) coupled to antigenic 
proteins in mice bearing different frequencies of CD4 § T cells. PC-reactive  GC were identified 
by staining frozen splenic sections with peanut agglutinin (PNA) and with monoclonal Abs 
against  AB1-2,  a dominant idiotope of T15 + anti-PC antibody. The nucleotide sequences of 
rearranged T15 V.1 genes were determined from polymerase chain reaction amplifications  of 
genomic DNA from microdissected GC B cells. T15 + GC became fully developed by day 6-7 
after primary immunization of euthymic mice with either PC-keyhole limpet hemocyanin (KLH) 
or PC-chicken gamma globulin (CGG). Yet the V.1 gene segments recovered from the primary 
GC as late as day 10-14 had low numbers of mutations, in contrast to responses to the haptens 
nitrophenyl or oxazolone that sustain high levels of hypermutation after  GC formation. PC- 
reactive B cells proliferate in histologically typical GC for considerable periods with no or little 
somatic hypermutation; the signals for GC formation are independent of those for the activation 
of hypermutation. We then examined GC 7 d after  secondary immunization with PC-KLH 
in euthymic mice, in nu/nu mice reconstituted with limited numbers of normal CD4 § cells 
before priming (CD4 §  and in nu/nu mice. All of these animals develop T15 + GC after 
antigen priming, however, the patterns of V gene mutations in the secondary GC reflected the 
levels of CD4 § cells present during the primary response. VDJ sequences from secondary GC 
of euthymic mice were heavily mutated, but most of these mutations were shared among all 
related (identical VDJjoints) sequences suggesting the proliferation of mutated, memory B cells, 
with little de novo somatic hypermutation. In contrast, the patterns ofV gene diversity in secondary 
GC from CD4 +-nu/nu mice suggested that there was ongoing mutation and clonal diversifica- 
tion during the first week after rechallenge.  The secondary  GC from T  cell-deficient, nu/nu 
mice showed little evidence for mutational and/or recombinational diversity of T15 + B cells. 
We conclude that the participation of CD4 § helper cells is required for full activation of the 
mutator in GC and takes place in a dose-dependent fashion. 
W 
ithin secondary lymphoid tissues,  two distinct cel- 
lular  compartments,  the  Ab-forming cell  (AFC) 1 
loci and germinal centers (GC), participate in the primary 
Ab response; both are discrete, pauciclonal cell populations 
(reviewed in 1, 2). Foci are aggregates of plasmablasts  and 
plasma cells at the periphery of the periarteriolar lymphatic 
sheaths and are the major source of early circulating Ab. GC 
Abbreviations used in this paper: AFC,  antibody-forming cells; ALPH, 
alkaline  phosphatase;  Ars, p-azophenylarsonate;  CGG, chicken  gamma 
globulin;  EPC,  p-nitrophenyl-6-(o-phosphocholine)hydroxyhexanoate; 
FDC,  follicular  dendritic  cell; GC,  germinal center;  Id,  idiotope;  NP, 
(4-hydroxy-3-nitrophenyl)acetyl;  PC, phosphorylcholine;  phOx, 2-phenyl- 
oxazolone;  SA, streptavidin. 
are well-defined structures in the lymphoid follicles  that contain 
B cells undergoing antigen-driven proliferation and are the 
source of the affinity-selected mutant clones that dominate 
the memory response (3-5). B cells in GC are readily identified 
by avid binding of the lectin, PNA (6). 
The somatic evolution of B cells has been studied inten- 
sively by analysis of hybridomas produced at different stages 
of the Ab response (reviewed in 7-9).  Recently, it has be- 
come possible to recover antigen-specific  B cells from individual 
GC and loci by microdissection, allowing direct analysis of 
their rearranged Ig V region genes (3, 10, 11). These studies, 
which examined primary Ab responses  to the hapten, (4- 
hydroxy-3-nitrophenyl)acetyl (NP),  showed  that  somatic 
hypermutation of V genes is confined to B cells within the 
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analyzed by day 8 of the response  (11). These results  were 
elegantly confirmed by McHeyzer-WiUiams et  al.  (12) in 
studies on single,  NP-specific/PNA-binding B cells. Simi- 
larly,  using the hapten 2-phenyl-oxazolone (phOx),  Berek 
et al. (5) readily found mutations in V genes among PNA- 
binding B cells derived from GC 10-12  d after immuniza- 
tion. Thus, it appears that the GC environment becomes com- 
petent to activate  hypermutation in hapten-reactive B cells 
by the beginning of the second week of the primary response. 
GC formation is a complex process that requires  interac- 
tions of B cells with T cells (13-15), follicular dendritic cells 
(FDC) (16-18), antigen-Ab complexes (19), and complement 
(20-21).  Further, it has been suggested that not all B cells 
are competent to enter the GC differentiation pathway (22). 
These considerations raise a number of questions regarding 
the relationship between the GC reaction and the initiation 
of somatic hypermutation. Two of these questions are ad- 
dressed in the present study: (a) Is hypermutation constitu- 
tively active in all GC B cells? (b) How do T cells influence 
the formation of GC and IgV gene hypermutation? We have 
explored these issues using a well-characterized antigen, the 
phosphorylcholine hapten (PC) (23, 24). Abs specific for PC 
are encoded by the V,1 segment of the V.$107 gene family 
in combination with the DFL16.1  and J.1 gene segments, 
and share the T15 idiotype (Id). A single immunization with 
PC-protein conjugates induces a strong GC response in the 
spleen (25) and primes the host for memory responses (23). 
PC-reactive GC are readily identified in frozen sections by 
staining with anti-Id (25),  as in the case of the response  to 
NP. Given the restricted V gene use and similar kinetics of 
Ab production and GC formation between the anti-PC and 
anti-NP responses,  it seemed appropriate to investigate so- 
matic hypermutation of the T15 genes of anti-PC Ab using 
the NP system as a reference point. Regarding the contribu- 
tion of T cells, we have recently observed that T cell-deficient 
nu/nu mice immunized with PC-protein conjugates develop 
histologically normal GC in the spleen in the absence of a 
primary Ab response (25). This model has been used in the 
present study to delineate the relationship between GC for- 
mation and somatic hypermutation in the pathway to the 
B cell memory. 
Materials and Methods 
Mice.  BALB/c  Tac, C57BL/6 Tac, and BALB/c  NTaC athymic 
(nu/nu) mice (atl 2 mo of age) were purchased from Taconic Farms 
Inc. (Germantown, NY). All mice were maintained in a restricted 
animal room in  sterile microisolator cages (Lab Products, Inc., 
Maywood, NJ) on a 12-h day/night cycle. 
Antigens and lmmunization,  p-nitrophenyl-6(0-phosphocholine) 
hydroxyhexanoate (EPC) conjugated to KLH (Sigma Chemical 
Co., St. Louis, MO) according to Spande (26) (EPC-KLH) was 
kindly provided  by Dr. James J. Kenny (National Cancer Institute, 
Frederick, MD). Preparation of PC conjugates of chicken gamma 
globulin (CGG) and BSA (both from Sigma Chemical Co.) was 
previously  described (25). Conjugates of NP (Cambridge Research 
Biochemicals, Cambridge, UK) with KLH and BSA were also de- 
scribed previously (27). All antigens were administered as a single 
intraperitoneal injection of 100/~g of haptenated protein in PBS 
on day 0 (primary response) and day 35 (secondary response). In 
one experiment, NP-KLH (100/~g) was administered  in alum (27). 
Cohorts of mice were bled from the tail vein and killed by cer- 
vical dislocation at various intervals after primary or secondary  im- 
munization. Recovered  spleens  were processed  either for AFC assay 
in suspension (see below) or for histology and DNA amplification 
(10, 25, 27). Serial, 6-/~m-thick  frozen sections of spleen were cut 
in a cryostat microtome, thaw-mounted onto silanated glass slides 
(Digene Diagnostic, Inc., Beltsville, MD), air-dried for 20 min, 
fixed in acetone for 10 min, and stored at  - 70~  In some experi- 
ments, about two thirds of  each spleen  was frozen and the remainder 
was used for AFC assay. 
Lymphocyte Pre~rations  and Cell Transfer.  Splenocyte  suspensions 
were prepared by teasing spleens in RPMI  1640 medium sup- 
plemented with 25 mM Hepes (GIBCO BRL, Galthersburg, MD) 
and 0.5% BSA (Sigma  Chemical  Co.). T lymphocytes  were depleted 
by two treatments with a cocktail ofmAb H013-4 (anti-Thy 1.2), 
GK 1.5 (anti-CD4), and 3.155 (anti-CD8) from ascitic  fluids (from 
the American Type Culture Collection, Rockville,  MD) for 30 min 
at room temperature, followed  by a pretested, normal rabbit serum 
as a source  of  comphment for 40 min in a 37~  bath. The resulting 
B cell  fraction  contained  <1% Thy 1.2-positive  cells  by FACS  |  anal- 
ysis (Becton Dickinson & Co., Mountain View, CA). 
T cell-enriched splenocyte  populations were prepared by filtra- 
tion through nylon wool columns (Wako BioProducts, Richmond, 
VA) using the manufacturer's protocol Nonadherent cells were 
treated once with mAb 3.155 plus rabbit complement to eliminate 
CD8 + T cells. The resulting T cell fractions contained >80% of 
Thy 1.2+/CD4 + cells, <10%  of slg + cells and <2%  of CD8 + 
cells as determined by FACS  |  analysis. 
Cells for adoptive transfer were resuspended in 0.5 ml of PBS 
containing 1% (vol/vol) of normal mouse serum and injected in 
the tail vein 16 h before immunization. 
FACS  |  Analysis.  Cells  were incubated with biotinylated goat 
anti-mouse Ig (Fisher  Biotech, Pittsburgh, PA) or with biotinylated 
anti-Thy 1.2 (Becton Dickinson & Co.) followed by staining with 
streptavidin-FITC (Fisher Biotech). The binding of mAb GK1.5 
and 3.155 was visualized with goat anti-rat Ig-FITC conjugates 
(Fisher Biotech). Cells were analyzed by flow cytometry. 
Serum A8  Levels  of PC-specific Ab were determined by stan- 
dard ELISA techniques using PC-BSA as Ag in solid phase and 
goat anti-mouse (polyvalent)  Ab labeled  with ~/-gahctosidase  (Fisher 
Biotech) as probes. Serum Ab concentrations (#g/ml) were deter- 
mined by extrapolation from a standard curve. 
Enumeration of AFCs.  Splenocytes  producing PC-specific Ab 
of  different  isotypes  were enumerated  by a modified  ELISPOT assay 
(25). Spleen cells  were suspended  in RPMI 1640 medium with 5% 
FCS and distributed into 96-well, round bottom culture plates 
(Costar, Cambridge, MA) in triplicate aliquots of 1-3  x  10  s cells 
in 100/~1. Nitrocellulose  filter sheets (0.45-#m pore size; Schleicher 
& Schuell, Keene, NH) were coated with a solution of PC-BSA 
(100/~g/ml  in PBS) overnight at 4~  and then incubated in a 
blocking solution of 10% BSA in PBS for 2 h at 37~  Filters  coated 
with BSA were used as controls. Nitrocellulose filters were placed 
on the top of culture plates and held firmly in place with the lid 
using binder clips. Cells were transferred onto the nitrocellulose 
by turning the plate upside down and placing it in a 37~  incu- 
bator with 5% CO2 for 4 h. Filters were then washed under tap 
water, treated with PBS-EDTA (10 mM) for 10 rain and rinsed 
in PBS. Bound PC Ab "spots" were visualized by staining with 
biotin-labeled goat Abs to mouse IgM, IgG, and IgA followed  by 
a streptavidin-alkaline  phosphatase (SA-ALPH)  conjugate (all from 
1320  Somatic  Diversity of IgV Genes Fisher Biotech) and a substrate (ProtoBlot  |  NBT/BCIP Color De- 
velopment System, Promega Corp., Madison, WI). Spots were 
scored under a magnification of 15 and expressed as means from 
triplicates. Cells producing NP-specific Ab, which exhibit heter- 
oditic binding to the NP analogue, (4-hydroxy-5-iodo-3-nitrophe- 
nyl)acetyl (NIP), were enumerated on falters coated with a solu- 
tion (100/zg/ml in PBS) of NIP-BSA conjugate (27); the procedure 
was otherwise the same as described for PC. 
Immunohistochemistry.  PC-specific  B cells in situ were identified 
using the previously described (28) mAb AB1-2 with specificity 
for the T15 Id, which was conjugated with biotin-N-hydroxy suc- 
cinamide (Vector Laboratories, Inc., Burlingame, CA), followed 
by SA-ALPH and nitroblue tetrazolium and 5-bromo-4-chloro- 
indoylphosphate  (Fisher Biotech) as substrate. Staining with AB1-2 
overlaps with that of  PC-BSA-biotin  and splenic sections  from mice 
immunized with antigens other than PC hapten do not stain with 
AB1-2, demonstrating the specificity  of the AB1-2 probe for PC- 
binding  B cells in  situ  (25, 29). GC B cells that bind  PNA 
(PNA +) were visualized  with PNA conjugated to horseradish  per- 
oxidase (HKP; E.Y. Laboratories, Inc., San Mateo, CA) and a sub- 
strate, 3-amino-9-ethyl-carbazole  (Sigma  Chemical  Co.). FDC were 
detected with a rat mAb, FDC-M1 (a kind gift from Dr. Marie 
Kosco, Basel Institute for Immunology, Basal, Switzerland), fol- 
lowed by a goat anti-rat Ig Ab conjugated to the appropriate en- 
zyme, ALPIq or HRP (Fisher Biotech). 
Frozen sections were rehydrated in PBS, blocked by incubation 
with PBS containing 10% BSA (1 h), incubated with the primary 
Ab (60 rain), washed three times in PBS/BSA and incubated either 
with a secondary  Ab-enzyme conjugate or with a SA-enzyrne  con- 
jugate.  The appropriate substrate was  added according to  the 
manufacturer's instructions. 
Enumeration of  GC and Isolation of  B Cells.  Splenic  sections  were 
double stained with AB1-2 and PNA as described above. GC were 
enumerated as PNA-stained areas within lymphoid follides and the 
number was expressed as a percentage of all foUides in the section 
(mean from two sections). Calls ("~100) were recovered from in- 
dividual AB1-2  + and PNA § GC using a sharpened micropipette 
controlled by an electrically  powered  micromanipulator (Narishige, 
Tokyo, Japan) as previously described (3,  10). 
Amplification and Sequencing of VDJ DNA Recovered  from Individual 
GC.  Cellular  material microdissected  from single AB1-2  § PNA + 
GC was incubated with proteinase K for 16 h at 37~  The pro- 
tease was subsequently heat inactivated (96~  10 min) and the 
crude cellular extract subjected  to two rounds of PCK amplification 
using nested primers, as previously described (3, 10). The initial 
round of 40 amplification cycles used primers identical to those 
described by Feeny and Theuraf ($107 and J. 1+4) (30). Internal 
primers were made complementary to codons 8-15, 5'ACGGAT- 
CCGGTGACCGTGGTCCTY (Kel-16) of the V1 segment and to 
the J.1  dement,  5'GGAGGAAGCTTGGTACAAGCCTGGGY 
(Kd-8). Ke1-16 and Kel-8 contain recognition sequences for the 
HindIII and BamHI restriction endonudeases, respectively. After 
two rounds of 40 cycles  of  PCK amplification,  DNA was extracted 
in phenol-chloroform,  precipitated  in ethanol, digested  with BamFII 
and HindlII (Boehringer Mannheim Biochemicals, Indianapolis, 
IN) and ligated into pBhescript SK  § (pBSK§ (Stratagem Cloning 
Systems, La Jolla, CA) as described (3,  10). Competent  DH5cr 
bacteria were transformed by electroporation and recombinant 
colonies screened with a 32p-labeled oligonucleotide  corresponding 
to positions 60-67 of the V1 gene segment. DNA from positive 
dones was sequenced as previously described (3,  10). 
Frequency and Distribution of Mutations Introduced by the PCR. 
A Taq polymerase error rate of 3.5  x  10 -s misincorporations/ 
bp/PCg cycle was determined by sequencing 71 VDJ clones re- 
covered from six independent amplifications of 50-200, acetone- 
fixed hybridoma cells (11 and not shown). This rate and the kinds 
of mutations observed (not shown) are typical of this error-prone 
polymerase (31, 32). On average,  we observed  0.72 artifactual mu- 
tations/V,1  gene segment (258 bp), a frequency nearly identical 
to that observed for the V186.2 exon (11). 
Within a collection of cloned VDJ fragments, artifactual muta- 
tions follow the Poisson distribution and the expected numbers 
of VH segments containing 0, 1, 2  ....  n polymerase errors may 
be calculated  (12, and see Fig. 4). Thus, in the absence of any muta- 
tional activity in vivo, 48.6% of amplified  V.1 segments will con- 
tain 0 mutations, 35.1% will contain 1 exchange, and 12.7, 3.0, 
0.5, and 0.1% will contain 2, 3, 4, and >15 Taq errors, respectively. 
Significant departure from this baseline distribution indicates true 
Ig hypermutation and is a more sensitive  measure than comparison 
of average mutation frequencies. 
Although GCs have been demonstrated to contain paucidonal 
B cell populations (10), litth junctional diversity is found in VDJ 
joints of primary, anti-PC B cells (33). For this reason, we analyze 
VDJ fragments recovered  in the primary response only  in reference 
to the GC from which they originated. VDJ joints show greater 
diversity in secondary responses and are informative with regard 
to clonal relationships. 
1~esults 
Ab  Responses  to  the  PC  Hapten  in  Normal  and  nu/nu 
Mice.  Features of PC-specific  Ab responses in normal, eu- 
thymic mice to immunization with EPC-KLH are shown 
in Table 1 (group A). The rise of primary PC-specific serum 
Ab coincided with the appearance of splenic AFC that were 
predominantly IgM producers. In addition, the majority of 
the splenic lymphoid follicles (>60%, Table 1) contained well- 
developed, PNA + GC that included calls expressing AB1-2, 
a major T15 Id of PC-binding Ab (Fig.  1 a). This staining 
was not due to the deposition of immune complexes in the 
network of the FDC, as demonstrated by dual staining of 
adjacent splenic sections with anti-Id and the FDC-spedfic 
mAb, FDC-M1 (Fig.  1 b). Under high magnification, Id + 
lymphocytes could be clearly separated  from FDC (Fig.  1 
c). Similar results were obtained by immunization with PC- 
CGG (25,  and Miller,  C., and J.  Stedra). 
Secondary challenge of euthymic mice with EPC-KLH at 
4 wk after priming resulted in a sixfold increase of serum 
Ab and an isotype switch of the splenic AFC from IgM to 
IgG and IgA (Table 1). All lymphoid follicles in these spleens 
were occupied by secondary PNA § GC (Table 1) that con- 
tained cells expressing  the AB1-2  Id (not shown). 
The role of T helper cells in the GC formation and devel- 
opment of humoral memory in response to EPC-KLH was 
studied by adoptive ceU transfer into nu/nu mice. Nu/nu mice 
reconstituted with normal,  syngeneic CD4 + lymphocytes 
(Table 1, group B) produced lower levels of PC-specific  Ab 
than euthymic controls, but the patterns of GC development, 
isotype switching, and memory response were similar in both 
groups. It should be noted that nu/nu recipients of 2  x  107 
splenic CD4 + lymphocytes had approximately fivefold fewer 
splenic  Thy 1.2+/CD4 + cells than did euthymic controls 
(Fig. 2). T cell engraftment remained at these low levels for 
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 Figure  1.  A splenic GC at day 7 after 1  ~ immuniza- 
tion with EPC-KLH. Adjacent sections were stained (a) 
with PNA (red) and AB1-2 anti-Id (blue),  and (b) with 
AB1-2 anti-Id (red) and the mAb FDC-M1 against FDC 
(blue). (c) Higher magnification (￿  1,000) of the GC from 
b. Note the distinct localization of Id + lymphocytes (red) 
and FDC (blue). 
the 35-d interval between antigen priming and challenge. This 
low T cell frequency may have produced the distinct pattern 
of somatic diversity of T15 V. genes in these animals  (see 
below). 
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Figure 2.  Relative numbers ofT lymphocytes (percentage of nucleated 
cells) detectable with anti-Thy 1.2 (unshaded columns) or anti-CD4 (shaded 
columns) in the spleens of euthymic BALB/c mice (pool of three spleens), 
thymus-deficient  (nu/nu)  mice and nu/nu  mice reconstituted  with 2  x 
107 normal syngeneic CD4 + T cells 7 or 35 d before the assay (mean from 
four animals  +  SD). 
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nu/nu  mice that did not receive T  cells failed to produce 
Ab to EPC-KLH, however,  they did develop GC (Table 1, 
group C) containing antigen-specific,  AB1-2 Id § B cells, as 
reported in detail elsewhere (25). Moreover, these mice were 
primed for a vigorous anamnestic IgM response to EPC-KLH, 
which became apparent upon reconstitution of the animals 
with  normal,  unprimed CD4 §  lymphocytes immediately 
before secondary challenge (Table 1, group C-2). Secondary 
Ab responses of the animals in group C-2 averaged sixfold 
higher  than  the  primary  responses  of group  B  (CD4 +- 
nu/nu)  and were comparable to their secondary responses. 
The humoral immunity  elicited by immunogenic  conjugates 
of PC is distinctive in that the IgM isotype dominates the 
primary anti-PC response in BALB/c (Igh  a) mice.  In con- 
trast,  the response of C57BL/6  (Igh  b)  mice to  NP-CGG 
switches to IgG by day 7-8 after immunization (27). As shown 
in Table 2,  the primary AFC responses  of C57BL/6 mice 
to EPC-KLH and NP-KLH were mostly IgM and IgG, respec- 
tively, suggesting that the PC- and NP-reactive B cells main- 
tain their characteristic  properties for isotype switch regard- 
less of the protein carrier  and responder mouse strain. 
T15 VH Sequences  from Primary GC of  Euthymic Mice Con- 
tain Few or No Mutations.  VDJ fragments were recovered 
from four AB1-2 +/PNA § GC after primary immunization 
of euthymic mice with either EPC-KLH (GC K. 1 and K.2) Table  2.  Ig Isotypes in Primary Ab Responses of C57BL/6 Mice to EPC-KLH and NP-KLH 
Hapten-specific AFC/106  splenocytes* 
Ratio 
Antigen*  IgM  IgG  IgA  IgG/IgM 
EPC-KLH  344  _+  81 s  33  •  5  25  •  8  0.09 
NP-KLH  37  •  6  170  •  24  <1  4.6 
NP-KLH/Alum  501  _+  83  >1,50011  14.2  >3.0 
* C57BL/6 mice (three to four/group) were immunized with 100/~g i.p. of indicated antigen. 
* AFC were enumerated by hapten-specific  ELISPOT assay on day 7 after the primary immunization as described  in Materials and Methods. 
$ Mean/group  _+ SD. 
II The count was uniformly >150 spots/10  s splenocytes  plated. 
or PC-CGG (GC C5.1 and C8.1) (Figs. 3 and 4). The K.1 
and K.2 GC were taken from different animals at day 10 and 
day 12, respectively, after immunization; the C5.1 and C8.1 
GC were dissected from different sites in the same spleen at 
day 12. From each GC, 10 sequences (258 bp) of rearranged 
V.1J.1  DNA segments were compared with the canonical 
TEPC15 VDJ sequence and nucleotide substitutions  in V. 
(to codon 95) were analyzed (Fig. 3). 
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I  ranged V,1  (T15)  segments  from 
T  splenic GC after 1  ~ immunization 
of euthymic mice with EPC-KI.H 
(a and b) and PC-CGG (c and d). 
Four individual GC were sampled 
at the following intervals after the 
T  immunization: (a) K.1, day 10; (b) 
Z.2, day 12; (4 C5.1; and (a) C.S.1, 
day 12. Vertical bars show the psi- 
tion of codons containing nucleo- 
tide differences between the done 
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T  mutation,  and crossed  bars  show 
stop codons. 
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from GC C5.1 (A), C8.1 (I), K1 ([]), and K2 (O) as compared  with 
the expected,  normal  distribution of artifactual  mutations due to Taq poly- 
merase errors (O). 
On average, each 258-bp V.1 exon rescued from a GC by 
PCR amplification is expected to contain about one muta- 
tion due to Taq polymerase error (1/330;  see Materials and 
Methods). The mutation frequencies observed in three of the 
primary GC were within the range of polymerase error: K.1  = 
1/660 bp,  C5.1  =  1/375 bp,  and C8.1  =  1/330 bp,  sug- 
gesting that  these B cells did not undergo hypermutation 
in vivo. In contrast, the K.2 sequences contained a significant 
excess of misincorporations (1/200)  indicating Ig somatic 
hypermutation. 
A more rigorous test for active hypermutation is analysis 
of the distribution of mutations observed among VDJ clones 
(Fig.  4) (see Materials and Methods).  When this test was 
applied to the V.1  segments recovered from primary GC, 
we found that the K.1 and C5.1 sequences contained distri- 
butions of mutations not significantly different from that ex- 
pected from polymerase error. However, despite the low fre- 
quency of mutations  in  the C8.1  clones,  these sequences 
contained excess multiple substitutions. Therefore, GC C8.1 
appears to have supported a low level of active hypermutation. 
However, both GC exhibiting signs of Ig hypermutation 
K.2 and C8.1, contain frequent shared mutations, a pattern 
typical of secondary responses to PC (see below). Thus it 
is possible that the K.2 and C8.1 GC were founded by sec- 
ondary B cell precursors stimulated and mutated by encounter 
with environmental antigens (34).  We cannot rule out that 
some mutations occurred by day 12 of the primary response; 
if they did occur, however, their frequency (pooled average  = 
1/391) is considerably below that observed in other primary 
antihapten responses (7,  8,  10,  11,  35). 
Hypermutation in  7"15 VH Sequences  from  Secondary GC: 
Correlation with TLymphocytes.  Secondary responses to EPC- 
KLH were elicited by restimulation at 35  d  after priming 
in one animal from experimental groups A  (euthymic), B 
(CD4 + cell-reconstituted nu/nu) and C-2 (nu/nu) (Table 2). 
Two GC were dissected from separate sites of each spleen 
on day 7 after secondary immunization. The names and origin 
of the recovered DNA  clones and  the main experimental 
findings are schematized in Table 3. 
The VDJ gene sequences that were amplified from the 
secondary GC of an euthymic mouse, E403 and E409,  re- 
presented  heavily mutated  V.1  segments  with  mutation 
frequencies of 1/121  and 1/48, respectively (Fig. 5 a). Sur- 
prisingly, most of these mutations were shared among all 
related sequences from individual GC, suggesting the prolifer- 
ation of previously mutated memory B cells rather than on- 
going somatic hypermutation within the secondary GC. The 
clonal relationship of B cells in these GC was further ap- 
parent from the identity of the CDR3 sequences (Fig. 6 a). 
Despite their extensive somatic diversity, sequences from both 
E403  and E409 GC had the canonical V.1/DFL16.1  T15 
joints between Asp in position 95 and Tyr in 96 which have 
been previously identified as key structural elements for the 
formation of PC-binding  Abs (33,  36).  However, the re- 
maining D, in E403 and E409 sequences could represent ei- 
ther somatically altered DFL16.1  genes or other, unidentified 
D. segments. 
The VDJ fragments recovered from the NT01 and NT02 
(Fig. 5 b) secondary GC of a nu/nu mouse reconstituted with 
CD4 + lymphocytes (CD4 +-nu/nu), were very different from 
those (E403  and E409)  recovered from euthymic controls. 
Table  3.  Summary  of Secondary GC 
Mutation 
Experimental group*  GC designation  Frequency (per bp)  V/D junctions  D. 
A  Euthymic  E403  1/121  T15 (D95/Y96)  Unknown 
E409  1/48  (shared mutations)  (mutated?) 
B  ,u/nu  + CD4 + T Cells  NT01  1/238  T15 (D95/Y96)  DFL6.1 
NT02  1/188  Diverse  Unknown 
C  nu/nui  N03  1/258  T15 (D95/Y96)  DFL6.1 
N04  1/372  Diverse  DFL6.1 
* See Table 1. 
* Antigen-stimulated nu/nu mice received unprimed CD4 + cells 1 d before Ag challenge. 
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Figure 5.  Comparison  of rearranged V. (T15) segments cloned from GC after 2  ~ immunization  with EPC-KLH. Mice were primed with EPC- 
KLH, challenged  35 d later, and sampled on day 7 after  challenge. (a) GC E403 and E409 from a euthymic  mouse; (b) GC NT01 and NT02 from 
a nu/nu mouse  reconstituted  with normal CD4 + T cells before  priming (Table 1, group B); (c) GC N03 and N04 from nu/nu mice that were primed 
without a T cell supplement (Table 1, group C). Nucleotide substitutions  are marked as in Fig. 3. 
Although the NT01  and NT02  sequences  had significant 
numbers of excess mutations (1/188 and 1/238, respectively) 
nucleotide substitutions were not typically shared among 
clonally related genes.  Indeed, several sequences from each 
GC could be readily arranged into genealogical trees (Fig. 7), 
indicating active mutational clonal diversification during the 
first week of the secondary response.  It should be remem- 
bered that the CD4 +-nu/nu mice had much lower numbers 
of T  cells  in  the  spleen  compared to  the euthymic mice 
(Fig. 2), which was reflected in less robust primary Ab re- 
sponses  (Table 1,  groups B vs.  A). 
As shown in Fig. 6 b, the NT01 CDR3 sequences repre- 
sent the canonical V.1/DFL16.1/J.1 gene rearrangement. In 
contrast, GC NT02 contained three distinct CDR3 sequences: 
(a) canonical T15 joints (nos. 6, 9-11),  (b) V.1 joined to an 
unknown D. segment (nos.  1-5, 8), and (c) a sequence (no. 
7), showing an alternative non-T15 junction between V,1 
and DFL16.1  with Asp -~ Val in position 95, followed by 
Asp and Tyr. This junction has been found previously in hy- 
bridomas generated from secondary responses to PC coupled 
to a protein carrier (33). 
We were particularly interested in sampling the V gene 
repertoire of secondary GC from the C-2 experimental group 
of nu/nu mice (Table 1), because these T cell-deficient mice 
developed  hapten-reactive  GC after primary immunization 
with EPC-KLH without any detectable Ab response.  They 
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Figure  6.  Amino acid sequences of CDR3 regions  of VDJ segments 
recovered from 2 ~ GC (Fig.  5) compared with the canonical T15 CDR3 
region.  Amino acids are identified by single-letter  code: Ala  =  A; Asp = 
D; Val  =  V; Tyr  =  Y. These sequence data are available from EMBL/ 
Gen.Bank/DDBJ under  accession  number U20978. 
received normal, unprimed CD4 + ceils, 1 d before challenge 
and the secondary GC were  sampled on day 7 (Fig.  5 c). 
Interestingly, the V~I sequences from one (N03) of the two 
GC analyzed demonstrated a frequency of mutations, 1/258, 
marginally greater than could be accounted for by Taq error; 
three sequences (nos. 10-12) contained three mutations each. 
Nonetheless,  the frequency and distribution of muhiple mu- 
tations in these animals are very similar to those observed 
in the K1 and C5.1 primary GC of euthymic mice (Fig. 4). 
All CDR3 segments from GC N03 resulted from canonical 
T15 (V,/DFL16.1/J,1) gene rearrangements (Fig. 6 c). The 
second GC, NO4, had an insignificant mutation  frequency 
of 1/372,  however, three sequences from this GC showed 
WD joint diversity with addition of Ala or Asp between 
positions 95 and 96 (Fig. 6 c). Such WD diversity is a hallmark 
of secondary responses to PC-protein conjugates (33). Thus, 
these GC show signs of mutational and/or recombinational 
diversity that are associated with an anamnestic anti-PC re- 
sponse even though the antigen priming was initiated in T 
cell-deficient  mice. 
Discussion 
Paucity of  Mutations in Primary PC-reactive GC.  We found 
few mutations  in the GC B cells by day 12 of primary re- 
sponses to PC-protein conjugates. When mutations were ob- 
served, their pattern suggested that the GC may have con- 
tained B cells that had been sensitized by prior environmental 
encounters with PC, an antigenic determinant of common 
bacteria such as Streptococcus pneumoniae or Proteus morganii 
(37,  38). 
This is in sharp contrast to other hapten-protein systems 
where the onset of IgV gene mutation  in vivo has been re- 
ported to be as early as day 7 after primary immunization 
(11, 12, 39); intensive hypermutational activity has been ob- 
served 10 d after immunization  with protein conjugates of 
oxazolone (7), Ars (8), and NP (10, 11, 35) haptens. Detailed 
studies by Jacob et al.  (10, 11) found that all GC between 
days 10 and 12 after immunization  with either NP-CGG or 
NP-KLH contained B cell clones with mutated IgV. genes. 
Thus,  unlike  NP-reactive  B  cells, PC-specific B  cells may 
proliferate in histologically  typical GC for some time with 
little or no somatic hypermutation. This period may last for 
a week or more, considering that fully developed GC occupy 
the majority of splenic lymphatic follicles by day 6-7 after 
immunization (Table 1 and 25). Since the protein carriers used 
here were the same used in studies that found early Ig muta- 
tion, it seems probable that the impoverished mutation reflects 
intrinsic differences between the NP- and PC-reactive B cells 
rather than insuf~cient T cell help. Our findings are consis- 
tent with the report by Levy et al.  (39)  who observed ex- 
tremely low mutation  frequencies (1/2,500 bp) among  40 
T15 V gene sequences recovered from mouse splenic cDNA 
libraries between day 5 and 13 after primary immunization 
with PC-KLH. 
PC-reactive B cells employing  the T15 V,1 gene clearly 
are capable of initiating Ig hypermutation, but it appears that 
the requirements to activate this mechanism may not be present 
in all anti-PC responses. For example, Claflin et al. (40-42) 
studied the somatic diversification of the V.I  gene  paired 
with different V~ genes  in response to the PC hapten ex- 
pressed on different  bacteria. They found only a modest degree 
of somatic  mutation  in  '~50%  of V.1/V~22  hybridomas 
generated after repeated immunizations  with S. pneumoniae 
PC (40).  In contrast, they found high levels of mutation in 
V.1/V~8 cells after a single immunization  with P. morganii 
PC (41, 42),  suggesting  that an element of P. morganii plays 
an important role in activation of the mutation mechanism. 
The origin of PC-reactive, T15 + B cells is a controversial 
matter in the literature. Two groups of investigators, using 
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ships of V, DNA sequences de- 
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adoptive  lymphocyte transfer  methodologies,  found  that 
T15 + antibodies were produced by the B-1 subset of B cells 
rather than by the conventional, bone marrow-derived, B-2 
lymphocytes (43, 44). However, these studies relied on the 
serological identification of the T15 Id. In contrast, Zarhary 
and Klinman (45) and Riley et al. (46) have reported a high 
frequency of precursor B cells in the bone marrow that give 
rise to T15 Id + clones expressing the canonical V.1/V~22 
genes. The importance of this issue for the present study is 
underscored by the fact that the B-1 cell subset in the mouse 
is believed to lack the capability of somatic hypermutation, 
based on the sequences of rearranged V genes from B-1 cells 
and lymphomas (47-49) as well as from hybridomas produced 
by fusion of peritoneal B cells (49,  50).  Moreover, Linton 
et al.  (22) have shown that peritoneal B-1 lymphocytes do 
not efIiciently form GC. It may be that the functional dis- 
tinctions between the B-1 and B-2 cell lineages are not abso- 
lute (51). If the T15 + B cells which occupy the splenic GC 
of PC-immunized mice and which undergo somatic hyper- 
mutation when properly stimulated belong to the B-1 lin- 
eage, the notion that this cell lineage lacks the mutation mech- 
anism and cannot form GC should be modified. 
The only apparent  phenotypic difference between NP- 
protein- and PC-protein-induced primary Ab responses is 
in Ig isotype (Table 2).  Whereas the anti-NP Ab switch to 
IgG within a week after immunization, the anti-PC Ab re- 
main predominantly IgM.  Could the latter hold a due to 
the delay of somatic hypermutation in T15 genes? It is gener- 
ally accepted that hypermutation occurs in V genes rearranged 
to either Cg or C3/and that isotype switch and mutation 
are independent events (8,  41,  52-55).  However, the two 
processes  may take place concurrently during the immune 
response, as suggested by Manser (8). There is a conspicuous 
concurrence ofisotype switch and initiation of mutation 7 d 
after immunization with NP-CGG  (10,  11). 
Abundance  of Mutations  in Secondary PC-reactive GC.  In 
marked contrast with the primary response, the T15 V.1 
genes from secondary GC of euthymic mice were heavily mu- 
tated. We cannot ascertain whether this reflects selective ex- 
pansion of memory B cells that underwent mutation in the 
late stages of the primary response, or whether it is the result 
of a rapid burst of mutational activity and donal selection 
within 7 d after antigenic challenge. However, the patterns 
of mutations argue in favor of the first alternative. Each sec- 
ondary GC was apparently occupied by closely related cells 
that have identical WD/J rearrangements and that shared most 
V, mutations, suggesting that relatively few mutations were 
introduced during the first week after restimulation. This 
is consistent with observations that the anamnestic Ab re- 
sponse is sometimes borne by rapidly expanding memory B 
cells that no longer mutate (8, 41, 53, 56-58) and it raises 
the intriguing possibility that the mutator is more active in 
the late primary GC than in early secondary GC. 
We note that mutations in the T15 V,1 genes generally 
spared codons specifying positions 33, 52, 95, and 100b that 
represent the contact residues for binding of the PC hapten 
(59).  A similar observation was made by Claflin et al. (40, 
41) on PC-reactive hybridomas from mice immunized with 
P. morganii. They speculated that the maturation of the Ab 
repertoire against P. raorganii PC involves the selection of mol- 
ecules that bind PC in context with a larger carrier epitope. 
Perhaps a similar interpretation pertains to EPC-KLH. 
T  Cells Regulate  the Pattern of $oraatic Diversity.  Insight 
into the process of somatic diversification of secondary GC 
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with  the  groups  of CD4 +  cell-reconstituted  nu/nu  mice 
(CD4+-nu/nu)  and  nu/nu  mice  (Table 3,  Figs.  5-7).  The 
memory B cells in CD4 +-nu/nu contained highly mutated 
T15 V,1 genes but, in contrast to euthymic animals,  these 
B cells represented a heterogeneous population of clones that 
appeared to be genealogically related based on the shared V 
gene mutations (Fig.  7). In other words, it appears that  at 
the time of Ag challenge, the development of the B cell reper- 
toire in the GC of euthymic mice had already reached an ad- 
vanced stage of selection and expansion  of a few memory 
clones that did not actively mutate, whereas in CD4 +-nu/nu 
animals,  which had approximately fivefold fewer T  cells in 
the spleen, the B cell repertoire was in an earlier evolutionary 
stage and the process of hypermutation was still active. Thus, 
the difference between euthymic and CD4 +-nu/nu mice in 
somatic  diversity  of memory  B  cells  correlates  with  the 
numbers of T  helper cells available  during the primary re- 
sponse. Although antigen-specific B cell proliferation occurs 
in  the PNA +  GCs  of nu/nu  mice  (25,  and Table 1),  this 
population expanded in a T-independent  manner shows no 
evidence for accelerated  maturation after restimulation in the 
presence of supplementary T  cell help (Table 3, Group C). 
The average frequency of V. mutations in this group (1/315) 
was not significantly different from that  found on days 10 
and 12 of the primary response (1/391) in euthymic animals. 
These patterns  of somatic diversity are best interpreted by 
the proposal that activation of hypermutation in GC via T 
cell help takes place in a dose-dependent fashion, reflecting 
perhaps,  the probability of individual B cells encountering 
the  critical  helper  signal(s)  during  their  proliferation  and 
differentiation  in the GC microenvironment. 
Collectively, our results show that the formation of GC 
and onset of IgV gene hypermutation are independent events 
and that both B and T  cells contribute to their regulation. 
Some antigen-reactive  B cells may proliferate in GC for lengthy 
periods without mutation,  as exemplified by the differences 
observed between the responses to the NP and PC haptens. 
Indeed, there may be a mechanism that regulates the hyper- 
mutation  process in trans between NP- and PC-reactive B 
cells (Miller,  C., and G. Kelsoe, manuscript in preparation). 
Results from nu/nu mice indicate that  the development of 
GC is much less dependent on T cell help than the activation 
of mutations,  and that the availability of help from T  cells 
influences the progression of somatic diversification of B cell 
clones. 
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